The International Myeloma Foundation is dedicated to improving the lives of multiple myeloma patients while working toward
prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
The next “Living Well with Myeloma” Teleconference will focus on approaches to relapsed myeloma. You won’t want to miss this FREE IMF teleconference followed by a Q&A session! Save the date and register now!
Join us for an unforgettable evening for an important cause. Laughter is the best medicine: It brings awareness and hope to the challenge of finding a cure for myeloma.
Enter to win a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii. Only 1000 tix will be sold @ $50 each. Get more information now!
On October 19, 2019, the IMF will host a Regional Community Workshop in Little Rock, AR in partnership with UAMS. Click here to learn more.
IMF Chairman Dr. Brian G.M. Durie reports on a busy week in myeloma, which included encouraging data from the phase III CANDOR clinical trial. “It is great to see an important new combination move forward in a positive fashion,” he says. The trial demonstrated a 37% reduction in the risk of progression or death in patients with relapsed or refractory multiple myeloma treated with Kyprolis + Darzalex + dexamethasone.
In this week’s video, Dr. Durie discusses just how close we are to discovering a method of preventing both MGUS, and the transition from MGUS to active myeloma.
Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.